VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TXNTexas Instruments Incorporated
$285.43$259.9B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTXNFinancials

Texas Instruments Incorporated (TXN) Financials

30Y historyFree accessUpdated daily

Revenue growth accelerated to 18.6% in 2026Q1, while the company maintained a robust 58.0% gross margin despite ongoing heavy depreciation from new fabrication investments.

TXN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue18.44B17.68B15.64B17.52B20.03B18.34B14.46B14.38B15.78B14.96B13.37B13B13.04B12.21B12.82B13.73B13.97B10.43B12.5B13.84B14.26B13.39B12.58B9.83B8.38B8.2B11.88B9.76B8.88B9.97B9.94B
Revenue Growth %14.89%13.05%-10.72%-12.53%9.18%26.85%0.54%-8.88%5.5%11.9%2.85%-0.34%6.88%-4.83%-6.63%-1.65%33.94%-16.59%-9.64%-2.95%6.44%6.45%27.92%17.31%2.22%-30.94%21.68%9.96%-11%0.32%-12.88%
Cost of Goods Sold7.87B7.6B6.55B6.5B6.26B5.97B5.19B5.22B5.51B5.35B5.13B5.44B5.62B5.84B6.46B6.96B6.47B5.43B6.26B6.5B7B7.03B6.95B5.87B5.31B5.82B6.12B5.07B5.61B6.18B7.15B
COGS % of Revenue-42.98%41.86%37.1%31.24%32.53%35.9%36.29%34.89%35.74%38.37%41.85%43.07%47.86%50.35%50.7%46.36%52.06%50.04%47%49.08%52.49%55.28%59.71%63.38%71.02%51.54%51.94%63.15%61.96%71.89%
Gross Profit10.57B10.08B9.09B11.02B13.77B12.38B9.27B9.16B10.28B9.61B8.24B7.56B7.43B6.36B6.37B6.77B7.49B5B6.25B7.33B7.26B6.36B5.63B3.96B3.07B2.38B5.75B4.69B3.27B3.79B2.79B
Gross Margin %57.32%57.02%58.14%62.9%68.76%67.47%64.1%63.71%65.11%64.26%61.63%58.15%56.93%52.14%49.65%49.3%53.64%47.94%49.96%53%50.92%47.51%44.72%40.29%36.62%28.98%48.46%48.06%36.85%38.04%28.11%
Gross Profit Growth %-10.88%-17.47%-19.98%11.27%33.52%1.15%-10.83%6.9%16.67%8.99%1.79%16.7%-0.06%-5.97%-9.61%49.87%-19.95%-14.84%1.02%14.08%13.1%42%29.06%29.15%-58.7%22.71%43.43%-13.79%35.76%-30.29%
Operating Expenses4.06B4.06B3.63B3.69B3.63B3.42B3.38B3.19B3.24B3.2B3.14B3.03B3.2B3.38B3.68B3.35B3.09B2.8B3.55B3.84B3.89B3.57B3.42B3B2.78B2.96B3.42B2.94B2.81B3.13B2.82B
OpEx % of Revenue-22.96%23.2%21.05%18.13%18.62%23.34%22.17%20.55%21.4%23.46%23.29%24.54%27.69%28.7%24.41%22.12%26.82%28.43%27.73%27.3%26.67%27.18%30.48%33.19%36.08%28.77%30.07%31.71%31.36%28.37%
Selling, General & Admin1.85B1.86B1.79B1.82B1.7B1.67B1.62B1.65B1.68B1.75B1.74B1.73B1.84B1.86B1.8B1.64B1.52B1.32B1.61B1.68B1.7B1.47B1.35B1.25B1.16B1.36B1.67B1.51B1.55B1.53B1.64B
SG&A % of Revenue-10.52%11.47%10.42%8.51%9.08%11.22%11.44%10.67%11.72%13.03%13.29%14.13%15.22%14.07%11.93%10.88%12.66%12.91%12.15%11.9%10.98%10.74%12.7%13.87%16.6%14.05%15.45%17.45%15.36%16.49%
Research & Development2.08B2.08B1.96B1.86B1.67B1.55B1.53B1.54B1.56B1.51B1.36B1.27B1.36B1.52B1.88B1.72B1.57B1.48B1.94B2.15B2.19B2.02B1.98B1.75B1.62B1.6B1.75B1.38B1.26B1.56B1.18B
R&D % of Revenue-11.78%12.52%10.63%8.34%8.47%10.58%10.73%9.88%10.08%10.14%9.75%10.41%12.47%14.64%12.49%11.24%14.16%15.52%15.58%15.4%15.05%15.72%17.78%19.31%19.49%14.71%14.13%14.25%15.6%11.88%
Other Operating Expenses3M117M-124M0257M196M222M00-60M39M33M00000000086M90M000048M039M0
Operating Income6.51B6.02B5.46B7.33B10.14B8.96B5.89B5.72B6.71B6.08B4.86B4.27B3.95B2.83B1.97B3.48B4.51B2.21B2.73B3.5B3.37B2.79B2.21B965M288M-582M2.34B1.7B399M615M-26M
Operating Margin %35.29%34.06%34.94%41.85%50.63%48.84%40.76%39.79%42.53%40.66%36.31%32.88%30.26%23.2%15.38%25.3%32.32%21.2%21.88%25.28%23.62%20.84%17.54%9.81%3.44%-7.1%19.7%17.38%4.5%6.17%-0.26%
Operating Income Growth %-10.21%-25.45%-27.7%13.17%52.02%2.99%-14.75%10.36%25.29%13.59%8.28%39.37%43.54%-43.22%-23.02%104.16%-19.16%-21.79%3.86%20.64%26.46%128.7%235.07%149.48%-124.88%37.91%325.06%-35.12%2465.38%-101.63%
EBITDA8.11B8.02B7.04B8.57B11.12B9.91B6.89B6.77B7.67B6.99B5.81B5.41B5.18B4.13B3.37B4.49B5.43B3.14B3.79B4.57B4.59B4.32B3.76B2.49B1.98B1.25B3.71B2.77B1.65B1.77B878M
EBITDA Margin %43.98%45.37%45.04%48.91%55.52%54.04%47.62%47.09%48.57%46.7%43.46%41.59%39.69%33.83%26.31%32.69%38.86%30.08%30.35%33.01%32.19%32.24%29.86%25.35%23.58%15.19%31.28%28.38%18.56%17.77%8.83%
EBITDA Growth %13.18%13.87%-17.79%-22.93%12.15%43.97%1.67%-11.66%9.73%20.26%7.45%4.44%25.38%22.38%-24.86%-17.27%73.05%-17.34%-16.93%-0.46%6.25%14.96%50.66%26.1%58.67%-66.46%34.12%68.18%-7.05%101.82%-61.41%
D&A (Non-Cash Add-back)1.55B2B1.58B1.24B979M954M992M1.05B954M904M955M1.13B1.23B1.3B1.4B1.01B913M925M1.06B1.07B1.22B1.53B1.55B1.53B1.69B1.83B1.38B1.07B1.25B1.16B904M
EBIT6.7B6.25B5.96B7.77B10.25B9.1B6.21B5.9B6.81B6.16B5.01B4.31B3.97B2.85B2.02B3B4.55B2.2B2.69B3.5B3.37B2.56B2.44B965M288M-582M2.34B1.75B456M666M-26M
Net Interest Income-556M-543M-508M-353M-214M-184M-190M-170M-125M-78M-72M-76M-81M-81M-45M-30M13M24M76M156M209M156M115M00000000
Interest Income00000000008M14M13M14M40M12M13M24M76M157M216M165M136M00000000
Interest Expense556M543M508M353M214M184M190M170M125M78M80M90M94M95M85M42M0001M7M9M21M00000000
Other Income/Expense-359M-313M-12M87M-108M-41M123M5M-27M-3M75M-58M-73M-78M-38M-520M37M26M44M195M258M196M214M285M-634M156M2.24B327M225M105M3M
Pretax Income6.15B5.71B5.45B7.42B10.03B8.92B6.02B5.73B6.69B6.08B4.93B4.22B3.87B2.75B1.94B2.96B4.55B2.02B2.48B3.69B3.63B2.75B2.42B1.25B-346M-426M4.58B2.02B617M713M-23M
Pretax Margin %33.34%32.29%34.86%42.34%50.09%48.62%41.61%39.82%42.36%40.64%36.87%32.43%29.7%22.56%15.09%21.51%32.59%19.34%19.85%26.69%25.43%20.57%19.24%12.71%-4.13%-5.19%38.55%20.69%6.95%7.15%-0.23%
Income Tax781M709M654M908M1.28B1.15B422M711M1.11B2.4B1.33B1.23B1.05B592M176M719M1.32B547M561M1.05B987M582M560M52M-2M-225M1.49B613M210M411M23M
Effective Tax Rate %12.7%12.42%11.99%12.24%12.79%12.89%7.01%12.41%16.54%39.44%27.08%29.17%27.18%21.5%9.1%24.33%29.07%27.12%22.61%28.47%27.23%21.13%23.13%4.16%0.58%52.82%32.57%30.36%34.04%57.64%-100%
Net Income5.37B5B4.8B6.51B8.75B7.77B5.59B5.02B5.58B3.68B3.6B2.99B2.82B2.13B1.76B2.2B3.23B1.47B1.92B2.66B4.34B2.32B1.86B1.2B-344M-201M3.06B1.45B452M1.84B63M
Net Margin %29.11%28.28%30.68%37.16%43.68%42.35%38.69%34.88%35.35%24.61%26.89%22.97%21.63%17.41%13.72%16.02%23.11%14.1%15.36%19.2%30.45%17.35%14.79%12.18%-4.1%-2.45%25.75%14.87%5.09%18.47%0.63%
Net Income Growth %10.14%4.21%-26.28%-25.59%12.61%38.86%11.52%-10.09%51.55%2.42%20.4%5.85%32.75%20.81%-20.08%-31.82%119.59%-23.44%-27.74%-38.79%86.79%24.88%55.34%448.26%-71.14%-106.57%110.75%221.02%-75.46%2823.81%-94.21%
Net Income (Continuing)5.37B5B4.8B6.51B8.75B7.77B5.59B5.02B5.58B3.68B3.6B2.99B2.82B2.16B1.76B2.24B3.23B1.47B1.92B2.64B2.64B2.17B1.86B1.2B-344M-201M3.09B1.45B452M339M-46M
Discontinued Operations000000000000000000000151M000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)5.875.455.207.079.418.275.975.245.593.613.482.822.571.911.511.882.621.151.451.842.781.391.050.60-0.20-0.121.710.830.261.130.05
EPS Growth %11.01%4.81%-26.45%-24.87%13.78%38.53%13.93%-6.26%54.85%3.74%23.4%9.73%34.55%26.49%-19.68%-28.24%127.83%-20.69%-21.2%-33.81%100%32.38%75%400%-66.67%-107.02%106.02%219.23%-76.99%2160%-92.86%
EPS (Basic)-5.455.247.139.518.386.055.335.713.683.542.862.611.941.531.912.661.161.471.882.841.421.080.62-0.20-0.121.780.860.261.170.05
Diluted Shares Outstanding914M913M919M916M926M936M933M952M990M1.01B1.02B1.04B1.08B1.11B1.15B1.17B1.21B1.27B1.32B1.45B1.56B1.67B1.77B2B1.72B1.68B1.79B1.75B1.77B1.59B1.52B
Basic Shares Outstanding909M909M912M908M916M923M921M936M970M991M995.98M1.01B1.05B1.1B1.13B1.15B1.2B1.26B1.31B1.42B1.53B1.64B1.73B1.93B1.72B1.68B1.72B1.69B1.74B1.54B1.52B
Dividend Payout Ratio-99.96%99.92%70%49.11%50.02%61.23%59.96%45.79%57.14%45.79%48.36%46.9%55.29%46.56%29.26%18.34%38.57%27.97%16%4.58%7.44%8.28%12.27%--4.61%9.23%29.42%7.11%204.76%

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Geopolitical supply chain disruption

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Rebound Signals Cyclical Recovery

According to the most recent quarterly filings, Texas Instruments achieved an 18.6% year-over-year revenue growth rate in 2026Q1, marking a significant departure from the contractionary trends observed throughout 2024 and suggesting that the company is successfully emerging from the industry-wide inventory correction cycle.

The acceleration to $4.8 billion in quarterly revenue indicates that demand in industrial and automotive end-markets is stabilizing. Investors should monitor whether this growth is driven by volume recovery or if pricing power remains intact as the company scales its 300mm manufacturing footprint.

Structural Margin Resilience Amid Expansion

As reported in financial statements, Texas Instruments maintained a gross margin of 58.0% in 2026Q1, demonstrating the company's ability to preserve pricing power and operational efficiency despite the heavy depreciation burden associated with its ongoing multi-billion dollar investment in new fabrication capacity.

The stability of gross margins near the 58% level suggests that the company's 300mm analog manufacturing strategy is effectively offsetting the inflationary pressures on input costs. This performance appears to validate the long-term thesis that internal manufacturing scale provides a durable competitive moat against fabless peers.

Operating Leverage Scaling With Volume

Based on the provided income statement data, operating income expanded to $1.8 billion in 2026Q1, reflecting a 37.5% operating margin that highlights the company's ability to leverage its fixed-cost structure as revenue growth accelerates following the previous period of underutilization.

The improvement in operating margins from the 32-33% range seen in 2025 suggests that management is successfully managing SG&A expenses while scaling production. This operating leverage is critical for maintaining profitability during the current capital-intensive phase of building out new fabrication facilities.

Earnings Quality Impacted By SBC

Analysis of recent filings reveals that stock-based compensation remains a variable component of the income statement, with a notable $210 million charge in 2025Q4, which warrants investor scrutiny regarding the true cash-generative capacity of the reported net income figures.

While net income remains robust, the volatility in stock-based compensation suggests that EPS growth may be periodically influenced by non-cash accounting adjustments. Investors should focus on the consistency of operating cash flow relative to these reported earnings to ensure that the quality of profit remains high.

Capital Intensity Risks Margin Compression

While the company reports strong margins, skeptics might argue that the massive capital expenditure cycle for new fabs could lead to future margin compression if industrial demand fails to sustain the current 18.6% growth rate observed in the most recent quarter.

The shift toward a higher fixed-cost base increases the risk of margin whipsaw if utilization rates drop unexpectedly. Investors should monitor whether the depreciation of these new assets will eventually weigh on net margins more heavily than historical averages suggest.

TXN — Frequently Asked Questions

Quick answers to the most common questions about buying TXN stock.

What was Texas Instruments Incorporated's (TXN) revenue in 2025?

For fiscal year 2025, Texas Instruments Incorporated (TXN) reported total revenue of $17.68B. This represents a 77.9% increase compared to $9.94B in 1996.

Is Texas Instruments Incorporated (TXN) profitable?

Texas Instruments Incorporated (TXN) is profitable, generating $5.00B in net income for the fiscal year ending 2025 with a net profit margin of 28.3%.

What is Texas Instruments Incorporated's operating profit margin?

Texas Instruments Incorporated (TXN) reported an operating income of $6.02B, resulting in an operating profit margin of 34.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Texas Instruments Incorporated's gross profit and gross margin?

Texas Instruments Incorporated (TXN) generated $10.08B in gross profit for the year, representing a gross profit margin of 57.0%. This demonstrates the company's core pricing power and production efficiency.